Covered recipient · General Payments record
JEREMIAH EUGENE NUGENT
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$2,335.62
- Reported across 154 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $373.41 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $137.57 | 3 |
| ABBVIE INC. | $78.98 | 4 |
| Novo Nordisk AS | $59.04 | 4 |
| PFIZER INC. | $50.23 | 3 |
| Almatica Pharma Inc. | $16.97 | 1 |
| CVRx Inc. | $16.43 | 1 |
| E.R. Squibb & Sons, L.L.C. | $14.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.33 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105136648 | CMS |
| ABBVIE INC. | $21.28 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105136650 | CMS |
| ABBVIE INC. | $17.97 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105136652 | CMS |
| ABBVIE INC. | $22.40 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105136654 | CMS |
| Almatica Pharma LLC | $16.97 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137573261 | CMS |
| AstraZeneca Pharmaceuticals LP | $25.05 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104733495 | CMS |
| AstraZeneca Pharmaceuticals LP | $98.15 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105240697 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.37 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105239702 | CMS |
| CVRx, Inc. | $16.43 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133855409 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.19 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101319322 | CMS |
| Novo Nordisk Inc | $14.97 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096918794 | CMS |
| Novo Nordisk Inc | $16.09 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096645179 | CMS |
| Novo Nordisk Inc | $14.80 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096828542 | CMS |
| Novo Nordisk Inc | $13.18 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097123512 | CMS |
| PFIZER INC. | $16.58 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130945616 | CMS |
| PFIZER INC. | $17.57 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131205674 | CMS |
| PFIZER INC. | $16.08 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131772733 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.